A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo

International Immunology

Volumn 15, Issue 6, 2003, Pages 711-720

  Beacock Sharp, Helen ^a   Donachie, Anne M ^a   Robson, Neil C ^a   Mowat, Allan M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adoptive transfer; CD4+ T cell; CD8+ T cell

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; ISCOM; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; IMMUNIZATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPH FOLLICLE; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TRANSGENE; VACCINE PRODUCTION;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; IMMUNIZATION; ISCOMS; LYMPHOCYTE ACTIVATION; MICE; OVALBUMIN;

EID: 0038620505     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg067     Document Type: Article

References (42)

1. Gupta, R. K. and Siber, G. R. 1995. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13:1263.
2. Levine, M. M., Kaper, J. B., Black, R. E. and Clements, M. L. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510.
3. Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A. 1984. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457.
4. Mowat, A. M. and Donachie, A. M. 1991. ISCOMS - a novel strategy for mucosal immunization? Immunol. Today 12:383.
5. Sjolander, A. Cox, J. C. and Barr, I. G. 1998. ISCOMS: an adjuvant with multiple functions. J. Leukoc. Biol. 64:713.
6. Smith, R. E., Donachie, A. M., Grdic, D., Lycke, N. and Mowat, A. M. 1999, Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses. J. Immunol. 162:5536.
7. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K. and McKenna, H. J. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
8. +lo thymocytes in vivo. Science 250:1720.
9. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R. 1994. T cell receptor antagonistic peptides induce positive selection. Cell 76:17.
10. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C. and Mathis, D. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
11. Mowat, A. M., Donachie, A. M., Reid, G. and Jarrett, O. 1991. Immune-stimulating complexes containing Quil-A and protein prime class-I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72:317.
12. Kearney, E. R., Pape, K. A., Loh, D. Y. and Jenkins, M. K. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
13. Garside, P., Steel, M., Worthey, E. A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F. Y. and Mowat, A. M. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154:5649.
14. + T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J. Immunol. 165:3136.
15. + T cells. J. Immunol. 159:591.
16. Pape, K. A., Kearney, E. R., Khoruts, A., Mondino, A., Merica, R., Chen, Z. M., Ingulli, E., White, J., Johnson, J. G. and Jenkins, M. K. 1997. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T-cells for the study of T-cell activation in vivo. Immunol. Rev. 156:67.
17. Kim, S. K., Schluns, K. S. and Lefrancois, L. 1999. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J. Immunol. 163:4125.
18. Merica, R., Khoruts, A., Pape, K. A., Reinhardt, R. L. and Jenkins, M. K. 2000. Antigen-experienced CD4 T cells display a reduced capacity for clonal expansion in vivo that is imposed by factors present in the immune host. J. Immunol. 164:4551.
19. Sun, J., Dirden-Kramer, B., Ito, K., Ernst, P. B. and Van Houten, N. 1999. Antigen-specific T cell activation and proliferation during oral tolerance induction. J. Immunol. 162:5868.
20. + T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation. Vaccine 19:1678.
21. + T cells in vivo. J. Immunol. 163:2561.
22. Mintern, J., Li, M., Davey, G. M., Blanes, E., Kurts, C., Carbone, F. R. and Heath, W. R. 1999. The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol. Cell Biol. 77:539.
23. Lefrancois, L., Olson. S. and Masopust, D. 1999. A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J. Exp. Med. 190:1275.
24. Kim, S. K., Reed, D. S., Olson, S., Schnell, M. J., Rose, J. K., Morton, P. A., and Lefrancois, L. 1998. Generation of mucosal cytotoxic T cells against soluble protein by tissue-specific environmental and costimulatory signals. Proc. Natl Acad. Sci. USA 95:10814.
25. + cytotoxic T cells by immunization with purified HIV-1 envelope proteins in ISCOMs. Nature 344:873.
26. van Binnendijk, R. S., van Baalen, C. A., Poelen, M. C., de Vries, P., Boes, J., Cerundolo, V., Osterhaus, A. D. and UytdeHaag, F.G. 1992. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176:119.
27. + T cell responses by oral and parenteral immunization with ISCOMS. Eur. J. Immunol. 25:2835.
28. Keene, J. A. and Forman, J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155:768.
29. Mitchison, N. and O'Malley, C. 1987. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17:1579.
30. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P. and Heath, W. R. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
31. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R. and Melief, C. J. M. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
32. Simmons, C. P., Mastroeni, P., Fowler, R., Ghaem-maghami, M., Lycke, N., Pizza, M., Rappuoli, R. and Dougan, G. 1999. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J. Immunol. 163:6502.
33. + T cells: CD4 independent help. J. Immunol. 167:1283.
34. Gratton, S., Cheynier, R., Dumaurier, M.-J., Oksenhendler, E. and Wain-Hobson, S. 2000. Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc. Natl Acad. Sci. USA 97:14566.
35. + T cell clones can provide B cell help. J. Immunol. 154:3118.
36. Pulendran, B., Lingappa, J., Kennedy, M. K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C. R. and Maraskovsky, E. 1997. Developmental pathways of dendritic cells in vivo. Distinct function, phenotype, and localization of dendritic cell subsets in Flt3 ligand-treated mice. J. Immunol. 159:2222.
37. Viney, J. L., Mowat, A. M., O'Malley, J. M., Williamson, E. and Fanger, N. A. 1998. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160:5815.
38. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E. and Maliszewski, C. R. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl Acad. Sci. USA 96:1036.
39. Kremer, I. B., Gould, M. P., Cooper, K. D. and Heinzel, F. P. 2001. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous Leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69:673.
40. Pawlowska, A. B., Hashino, S., McKenna, H., Weigel, B. J., Taylor, P. A. and Blazar, B. R. 2001. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice. Blood 97:1474.
41. Smith, J. R., Thackray, A. M. and Bujdoso, R. 2001. Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer cells and dendritic cells. Immunology 102:352.
42. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423.